CClinicalTrials.gg
CompletedNCT01138631Updated Mar 31, 2017

Selection of Embryos by Time-lapse

An interventional study of Embryoscope in Infertility, sponsored by University of Aarhus. Completed at 1 site in Denmark. Open to female participants aged Up to 37 Years. Per ClinicalTrials.gov, last updated 2017-03-31.

Sponsored by University of Aarhus · Not applicable, Interventional, and Basic science

Phase
Not applicable
Study type
Interventional
Enrollment
59
Allocation
Non-randomized
Ages
Up to 37 Years
Sex
Female
01

Study summary

In order to improve success rate by assisted reproductive techniques new techniques are being developed for selection of the embryo with best chance of implantation, establishement of pregnancy and subsequent delivery.The present study is based upon the hypothesis that time-lapse (frequent imaging) may give information about important steps in embryonic development, which could help to optimize selection of embryo(s) for treatment in IVF. The present study evaluates the outcome of conventional embryo culture with culture in a specially developed incubator equipped with a time-lapse system (Embryoscope).

Embryos from 50 IVF cycles (400 embryos) will be randomised to either conventional incubation or to culture in the Embryoscope. Embryos will be cultured for five days to the blastocyst stage. The primary endpoint is fraction of embryos developed to the four cell stage.

Read the detailed description

In vitro fertilization for infertility has a success rate on average in Europe of 25% in terms of baby take-home rate per cycle. One way to improve this rather low succes rate is to develop new measures for selection of the best embryo among peers as presently evaluated by embryo morphology. One of these promising methods is contineous imaging of embryo development by time-lapse. A new and unique equipment for this purpose - an Embryoscope - har been developed by Unisense Fertilitech. The present study evaluates embryo 4-cell rate during cultivation to blastocyst stage in a conventional incubator with 4-cell rate in the Embryoscope to ensure non-inferiority of the latter.

02

Conditions studied

  • Infertility

Browse trials for

Keywords

  • IVF, Infertility, embryo selection, embryoscope, time-lapse
03

In context

Infertility

2,506 studies on the registry are indexed under Infertility; 407 are open to participants now.

This study's enrollment of 59 is below the median of 120 across 1,698 interventional studies indexed under Infertility.

Browse Infertility studies →

Lead sponsor

University of Aarhus is the lead sponsor of 1,274 studies on the registry; 183 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
Up to 37 Years
Sexes eligible
Female
Accepts healthy volunteers
No

Inclusion criteria

  • Patients undergoing 2.nd or 3.rd IVF cycle with expected retrieval of 8 oocytes or more. Age \< 38 years

Exclusion criteria

Exclusion Criteria:

  • Endometriosis
05

Study design

Phase
Not applicable
Primary purpose
Basic science
Allocation
Non-randomized
Intervention model
Single group
Masking
None (open label)
Enrollment
59 participants (actual)

Study arms

  • Active comparator
    Embryoscope

    Device: Embryoscope

  • No intervention
    Conventional incubator

Interventions

  • DeviceEmbryoscope

    The embryoscope is an incubator with in-built photographic equipment

06

What researchers measure

Primary outcomes

  1. 4-cell rate

    Time frame: 2 days after oocyte pick-up

07

Study locations

1 site
  • Fertility Clinic, Aarhus University Hospital, Skejby
    Aarhus, Denmark
08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Mar 31, 2017, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT01138631
Lead sponsor
University of Aarhus
Collaborators
University of Copenhagen
First posted
Jun 7, 2010
Start date
Jun 2010
Primary completion
Dec 2010
Completion
May 2011
Last update
Mar 31, 2017

Study contacts

Jakob Ingerslev, DMSc
principal investigator · University of Aarhus

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in May 2011. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion